Literature DB >> 7522417

Immunotherapy with T-cell-reactive peptides derived from allergens.

B P Wallner, M L Gefter.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7522417     DOI: 10.1111/j.1398-9995.1994.tb02272.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  10 in total

1.  Vaccination with a multi-epitopic recombinant allergen induces specific immune deviation via T-cell anergy.

Authors:  Y Cao; M Yang; Z Luo; S S Mohapatra
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  PS80 interferes with the antiallergic effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, at very low concentration through modulation of Th1/Th2 balance.

Authors:  Daisuke Kozutsumi; Masako Tsunematsu; Taketo Yamaji; Rika Murakami; Minehiko Yokoyama; Kohsuke Kino
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

Review 3.  Dust mite allergens.

Authors:  G A Stewart
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

4.  Hyposensitization to allergic reaction in rDer f 2-sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119S.

Authors:  M Yasue; T Yokota; M Fukada; T Takai; M Suko; H Okudaira; Y Okumura
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

Review 5.  Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.

Authors: 
Journal:  CMAJ       Date:  1995-05-01       Impact factor: 8.262

Review 6.  Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.

Authors:  S R Prickett; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-06       Impact factor: 5.018

Review 7.  Advances in synthetic peptide immuno-regulatory epitopes.

Authors:  Peter Socrates Creticos
Journal:  World Allergy Organ J       Date:  2014-11-10       Impact factor: 4.084

Review 8.  Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.

Authors:  Mirela Curin; Musa Khaitov; Alexander Karaulov; Leyla Namazova-Baranova; Raffaela Campana; Victoria Garib; Rudolf Valenta
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-09       Impact factor: 4.806

9.  Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.

Authors:  Oluwatoyin Akinfenwa; Huey-Jy Huang; Birgit Linhart; Margarete Focke-Tejkl; Susanne Vrtala; Alina Poroshina; Alexandra Nikonova; Musa Khaitov; Nicholas J Campion; Julia Eckl-Dorna; Verena Niederberger-Leppin; Bernhard Kratzer; Peter Anton Tauber; Winfried F Pickl; Michael Kundi; Raffaela Campana; Rudolf Valenta
Journal:  Front Immunol       Date:  2021-10-26       Impact factor: 7.561

Review 10.  T Cell Epitope Peptide Therapy for Allergic Diseases.

Authors:  Robyn E O'Hehir; Sara R Prickett; Jennifer M Rolland
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.